(Q43077949)

13 November 2017

title

Tissue-factor fusion proteins induce occlusion of tumor vessels (English)

1 reference

13 November 2017

2

1 reference

13 November 2017

Christian Schwöppe

1

1 reference

13 November 2017

Thorsten Persigehl

3

1 reference

13 November 2017

Ruediger Liersch

4

1 reference

13 November 2017

Heike Hintelmann

5

1 reference

13 November 2017

Johannes Dreischalück

6

1 reference

13 November 2017

Janine Ring

7

1 reference

13 November 2017

Christoph Bremer

8

1 reference

13 November 2017

Walter Heindel

9

1 reference

13 November 2017

Rolf M Mesters

10

1 reference

13 November 2017

Wolfgang E Berdel

11

1 reference

13 November 2017

publication date

1 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

125 Suppl 2

1 reference

13 November 2017

page(s)

S143-50

1 reference

Induction of angiogenesis during the transition from hyperplasia to neoplasia

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Vascular targeting agents as cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Involvement of integrin alpha V gene expression in human melanoma tumorigenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Anti-cancer activity of targeted pro-apoptotic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Targeting tumor vasculature with homing peptides from phage display

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Generation of fusion proteins for selective occlusion of tumor vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Studies on plant amylases: The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

The neovasculature homing motif NGR: more than meets the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Spontaneous formation of L-isoaspartate and gain of function in fibronectin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Flipping the wound that doesn't heal: the upside of coagulation in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

Imaging cathepsin B up-regulation in HT-1080 tumor models using fluorescence-mediated molecular tomography (FMT).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

In vivo tomographic imaging of near-infrared fluorescent probes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

In vivo optical imaging of CD13/APN-expression in tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2810%2970033-5

7 January 2021

10.1016/S0049-3848(10)70033-5

Identifiers

DOI

1 reference

13 November 2017

1 reference